Identification of novel intracellular signaling molecules and clarification of their signal transduction mechanism which regulate abnormal vascular contraction.
Identification of novel intracellular signaling molecules and clarification of their signal transduction mechanism which regulate abnormal vascular contraction.
批准号:
14370014
负责人:
KOBAYASHI Sei
金额:
$9.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004
中文摘要
在日本,血管疾病的死亡率与癌症相当。据报道,C^<2+>-依赖性收缩(Ca^<2+>-敏化)在血管疾病中观察到的血管异常收缩中起关键作用。本研究的目的是鉴定新的细胞内信号分子,并阐明其信号转导机制。在第一年,我们发现鞘酰基磷酰胆碱(SPC)是一种诱导血管异常收缩的新介质。我们发现SPC通过依次激活Src家族酪氨酸激酶和rho激酶诱导Ca^<2+>敏化。第二年,为了寻找Src家族酪氨酸激酶的下游介质,我们重点研究了SPC诱导酪氨酸磷酸化的变化,并成功提取了一些作为Src家族酪氨酸激酶下游介质的分子。在第三年,我们获得了以下结果:1。建立了具有收缩能力的血管平滑肌细胞培养体系。sirna介导的Fyn的下调抑制了SPC诱导的培养血管平滑肌的收缩,表明Fyn参与了SPC诱导的信号转导。功能蛋白质组学分析发现p60、p160和p200是Fyn的下游介质。根据这些结果,我们确定Fyn是一种介导异常血管收缩的细胞内信号分子。此外,我们提出Fyn通过酪氨酸磷酸化p60、p160和/或p200诱导血管异常收缩。
英文摘要
Mortality of vascular diseases is comparable to that of cancer in Japan. It has been reported that C^<2+>-dependent contraction (Ca^<2+>-sensitization) plays a pivotal role in abnormal vascular contraction observed in vascular diseases. The purpose of this study was to identify novel intracellular signaling molecules and to clarify their signal transduction mechanisms.In the first year, we identified sphingosylphosphorylcholine (SPC) as a novel mediator to induce abnormal vascular contraction. We found that SPC induces Ca^<2+> psensitization through the activation of Src family tyrosine kinase and Rho-kinase in this orderIn the second year, in order to find the downstream mediators of Src family tyrosine kinase, we focused on the changes in tyrosine phosphorylation induced by SPC and we succeed in extracting some molecules as downstream mediators of Src family tyrosine kinase.In the third year, we obtained the following results :1.We established the cell culture system of vascular smooth muscle which has contractile ability.2.The siRNA-mediated knock down of Fyn inhibited the SPC-induced contraction of the cultured vascular smooth muscles, indicating the involvement of Fyn in the SPC induced signal transduction.3.The functional proteomics analysis identified p60, p160, and p200 as the downstream mediators of Fyn.From these results, we identified Fyn as an intracellular signaling molecule which mediates abnormal vascular contraction. In addition, we propose that Fyn induces abnormal vascular contraction through the tyrosine phosphorylation of p60, p160, and/or p200.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.febslet.2004.11.100
发表时间:
2005-01-17
期刊:
FEBS LETTERS
影响因子:
3.5
作者:
[Mogami, K, Kishi, H, Kobayashi, S]
通讯作者:
Kobayashi, S
DOI:
10.1161/01.res.0000042702.04920.bf
发表时间:
2002-11-15
期刊:
CIRCULATION RESEARCH
影响因子:
20.1
作者:
[Nakao, F, Kobayashi, S, Matsuzaki, M]
通讯作者:
Matsuzaki, M
Shirao S et al.: "Sphingosylphosphorylcholine is a novel messenger for Rho-kinase-mediated Ca^<2+> sensitization in the bovine cerebral artery : unimportant role for protein kinase C"Circulation Research. 91. 112-119 (2002)
Shirao S 等人:“鞘氨醇磷酸胆碱是牛大脑动脉中 Rho 激酶介导的 Ca^2 敏化的新信使:对蛋白激酶 C 的作用不重要”循环研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakao F et al.: "Involvement of Src family protein tyrosine kinases in Ca^<2+> sensitization of coronary artery contraction mediated by a sphingosylphosphorylcholine-Rho-kinase pathway"Circulation Research. 91. 953-960 (2002)
Nakao F等人:“Src家族蛋白酪氨酸激酶参与由鞘氨醇磷酸胆碱-Rho-激酶途径介导的冠状动脉收缩的Ca 2+ 敏化”循环研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1007/s00424-002-0945-3
发表时间:
2003-03-01
期刊:
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
影响因子:
4.5
作者:
[Yasukochi, M, Uehara, A, Berlin, JR]
通讯作者:
Berlin, JR
共 11 条
Elucidation of mechanism for production of causal factor of vasospasm
-
批准号:23659113
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2011
-
负责人:KOBAYASHI Sei
-
依托单位:
Identification of food component which selectively inhibits abnormal vascular contraction
-
批准号:23380077
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.15万
-
财政年份:2011
-
负责人:KOBAYASHI Sei
-
依托单位:
Clarification of molecular mechanisms of abnormal vascular contraction by functional proteomics and a single molecular analysis of signal transduction
-
批准号:20390059
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.73万
-
财政年份:2008
-
负责人:KOBAYASHI Sei
-
依托单位:
Functional roles of membrane domain and its localized component proteins in abnormal vascular contraction
-
批准号:17300128
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.07万
-
财政年份:2005
-
负责人:KOBAYASHI Sei
-
依托单位:
Molecular and cellular physiological studies on the intracellular signal transduction causing abnormal vascular contraction
-
批准号:11470012
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.9万
-
财政年份:1999
-
负责人:KOBAYASHI Sei
-
依托单位:
Development of the method(s) to monitor cardiovascular function and its intracellular signal transduction
-
批准号:09557005
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.58万
-
财政年份:1997
-
负责人:KOBAYASHI Sei
-
依托单位:
Regulatory mechanisms of cytosolic ion transients during cell cycle progression in vascular endothelial and smooth muscle cells
-
批准号:08457211
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$2.43万
-
财政年份:1996
-
负责人:KOBAYASHI Sei
-
依托单位:
REGULATORY MECHANISMS OF VASCULAR CONTRACTION AND CELL PROLIFERATION IN DIABETES MELLITUS
-
批准号:05837015
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.09万
-
财政年份:1993
-
负责人:KOBAYASHI Sei
-
依托单位:
海外基金